Pharmacyclics

Tackling Cancer: Leukemia's Biggest Current and Upcoming Players

Tackling Cancer: Leukemia's Biggest Current and Upcoming Players

Motley Fool

ASCO '13 Preview: Gilead's Big Cancer Debut

ASCO '13 Preview: Gilead's Big Cancer Debut

TheStreet.com

Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived

Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived

Seeking Alpha

Pharmacyclics says FDA grants Breakthrough Therapy Designation for ibrutinib

Pharmacyclics says FDA grants Breakthrough Therapy Designation for ibrutinib

Yahoo/Fly on the Wall

The Wild Story Behind A Promising Experimental Cancer Drug

The Wild Story Behind A Promising Experimental Cancer Drug

Forbes

The Best- And Worst-Performing Biotech Stocks In February

The Best- And Worst-Performing Biotech Stocks In February

Forbes

Tackling Cancer: The Current and Upcoming Players

Tackling Cancer: The Current and Upcoming Players

Motley Fool

Pharmacyclics Valuation Jumps Over $1 Billion On Newest Developments

Pharmacyclics Valuation Jumps Over $1 Billion On Newest Developments

Seeking Alpha

Pharmacyclics Still on a Roll After Earnings Results

Pharmacyclics Still on a Roll After Earnings Results

Motley Fool